Conclusions Comparing two groups, we did not find a correlation between maternal age, BMI or obstetric history and A.uterina flow index.
Objectives: Small-for-gestational-age (SGA) infants have an increased risk of stillbirth, particularly if their weight is <5 th percentile for gestational age. Growth scans are usually carried out for suspicion of SGA following symphysio-fundal height (SFH) measurements, unless there is another indication. We have reported a 29% antenatal detection rate for SGA infants <10 th percentile. We hypothesised that the detection would be better for more extreme SGA infants (birth weight <5 th percentile).
Methods: A retrospective cohort study was conducted between October -December 2017 in a large London hospital trust. Infants born with a birthweight <5 th percentile for gestational age (WHO criteria) after 36 weeks gestation were included. Exclusion criteria included multiple pregnancies, in-utero transfers, known fetal anomalies and late bookers. Patient demographics, pregnancy details and ultrasound scan data were collected using hospital computer databases. Results: Of 2454 infants, 119 babies were born <5 th birthweight percentile for gestational age, including 1 stillbirth. The median maternal age was 32 (range 19-45), BMI 22.5kg/m 2 (range 16.9-52.5 kg/m 2 ) and parity 0 (range 0-8).
The antenatal detection rate of SGA (<10 th percentile) was 33.6% (41/119). Growth scans were performed in 68.1 % (81/119) of cases. 70% of women diagnosed with a SGA infant had a scan within 2 weeks of delivery. 41 undiagnosed women received a growth scan, with 13 (31.7%) having a scan performed within 2 weeks of delivery which did not identify any concerns with fetal growth.
Conclusions: Most infants <5
th birthweight percentile were not diagnosed antenatally. The sensitivity for detection based on an ultrasound estimated fetal weight <10 th percentile was similar to that for SGA<10 th percentile. Despite regular antenatal SFH assessment and ultrasound scanning, SGA detection <5 th percentile is poor and does not fulfil the normally accepted criteria for a screening test. Objectives: Our previous work has demonstrated growth scans fail to diagnose 40% of SGA infants in whom an ultrasound scan was undertaken within 2 weeks of delivery. We aim to establish the relationship between the difference in estimated fetal weight (EFW) and birthweight (BW) in relation to the time interval between the ultrasound scan and delivery. Methods: A retrospective cohort study was conducted between October 2017 and December 2017 across two maternity units within one large inner-city London trust. Inclusion criteria included: (i) infants born SGA (WHO criteria), (ii) had a growth scan within 2 weeks of delivery and (iii) delivered after 36 weeks gestation. Exclusion criteria included multiple pregnancies, in-utero transfers, known fetal anomalies and late bookers. Patient demographics, pregnancy information and ultrasound scan data were collected from hospital databases. Results: 62 infants were included (100% livebirths). The median maternal age was 31, BMI 24kg/m 2 and parity 0. In 34/62 (53.1%) cases the EFW was greater than the BW. No correlation was seen between the change in weight since growth scan (BW-EFW) and the duration to delivery (Pearson correlation coefficient; r=0.16, p=0.22). Conclusions: The EFW at scan was greater than the final BW for over half of cases, despite the fetus remaining in utero for up to a further 2 weeks, suggesting that an ultrasound EFW performed within 2 weeks of delivery in SGA is a very poor predictor of BW. The lack of correlation between the change in weight between the final growth scan and delivery, and the number of days between these time points means that either growth scans in SGA at or near term are inaccurate for technical reasons, or that fetuses may either grow or shrink between the scan and delivery. Both explanations, which are not mutually exclusive, have clinically important implications.
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Added value of chromosomal microarray analysis above conventional karyotyping in stillbirth work-up: systematic review and meta-analysis Objectives: To establish the added value of chromosomal microarray analysis (CMA) above conventional karyotyping to assess the genetic causes of stillbirth. Methods: A systematic search was performed to identify relevant studies published in English and Spanish using PubMed, SCOPUS and ISI Web of Knowledge databases, without publication time restrictions. Observational studies of fetal losses >20 weeks of gestation assessed by CMA with at least 5 subjects analysed
